Wesley Potter Wheeler
Independent Member of the Supervisory BoardMr. Wesley Potter Wheeler, MBA, also known as Wes, serves as Executive in Residence at Frazier Management, L.L.C. since August 2026. He joined the firm in August 2026. In this role, he supports the firm’s investment professionals with diligence efforts and sector insights in life science logistics and infrastructure, while also advising portfolio leadership teams on operational performance, strategic growth initiatives and value creation. He serves as Chief Executive Officer and Director at LabConnect, Inc. since September 2024. He serves as Independent Member of the Supervisory Board at Evotec SE since June 10, 2024. He serves as Executive Chair of the Board at BioTouch since January 2024. He served as President of the Global Healthcare & Life Sciences (HCLS) Unit at United Parcel Service, Inc. since December 3, 2019. At UPS Healthcare, he built and led a new healthcare vertical and served as a primary industry interface to the US Government during Operation Warp Speed, overseeing logistics for the distribution of a number of COVID-19 vaccine doses to numerous countries. He joined the firm in 2016. He serves as President of UPS Healthcare at Polar Speed Distribution Limited since 2019. He serves as Director at Cairn Therapeutics, Inc., as Independent Director at Belhaven BioPharma Inc. and as Director at Envirotainer AB. His prior experience includes serving as Director at Keenova Therapeutics plc from February 2024 to July 31, 2025. He served as Chief Executive Officer and Director at Marken Limited, which he joined on May 25, 2011. He also served as a Member of the Advisory Board at the company. He served as Chief Executive Officer, President and Director at Patheon B.V., where he was employed from December 3, 2007 to December 1, 2010. He served as Chief Executive Officer of Patheon Inc. from December 3, 2007 to December 1, 2010, as President from March 27, 2008 to December 1, 2010 and as Director from December 2009 to December 1, 2010 and from December 3, 2007 to April 29, 2009. At Patheon, he led an operational and financial turnaround of the publicly traded contract manufacturer. He served as President of North American operations & Global Commercial Development at Valeant Pharmaceuticals International, which he joined in February 2003. In this role, he was responsible for its regional operations in the United States, Canada and Puerto Rico and for the company's commercial development activities and global marketing functions. He also served as President of Valeant Pharmaceuticals North America LLC. He served as Chief Executive Officer and President of DSM Pharmaceuticals Inc. from January 2002 to February 2003. He served at GlaxoSmithKline PLC as Senior Vice President of Logistics and Strategy from 1998 to 2002, where he was responsible for managing the manufacturing merger between Glaxo Wellcome and SmithKline Beecham. He also served as Vice President of Marketing at Glaxo Wellcome from 1997 to 1998 and as Senior Vice President of Global Manufacturing and Supply at Glaxo. He joined Glaxo in 1989. During his career at GlaxoSmithKline, he planned and launched the first-ever direct-to-consumer product-specific advertising campaign in the U.S. for the treatment of herpes, repositioned legacy products, accelerated development of new products and managed post-patent sales programs for key brands of the company. He also served at Exxon Research & Engineering Co. Mr. Wheeler has several years' experience in executive leadership across global healthcare and pharmaceutical businesses, with repeated CEO and Board Director roles at both private equity-backed and publicly traded companies. His career includes multinational experience in pharmaceutical manufacturing, sales and marketing, R&D and engineering. He has an M.B.A. in Finance from California Lutheran University and a B.S. in Mechanical Engineering from Worcester Polytechnic Institute.
Positions
- Company NameEvotec SEStock CodeEVOPositionIndependent Member of the Supervisory BoardColleagues
- CWChristian WojczewskiCEO & Chairperson of the Management Board
- DWDieter WeinandIndependent Chairman of the Supervisory Board
- ADAurelie DalbiezChief People Officer & Member of Management Board
- CHClaire HinshelwoodCFO & Member of Management Board
- IMIngrid MllerCOO & Member of Management Board
- JHJoanna HolbrookChief Scientific Officer & Member of the Management Board
- RSRoland SackersIndependent Vice Chairperson of the Supervisory Board
- CUConstanze Ulmer-EilfortIndependent Member of Supervisory Board
- DMDuncan McHaleIndependent Member of the Supervisory Board
